Study of the effect of sage on menopause

Interventional study on the effect of Sage (Saliva officinalis) extract on menopausal symptoms in postmenopausal women

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180130038557N1

Enrollment

Registered

2018-10-17

Start date

2018-06-20

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menoapuse,Menopause symptoms.

Interventions

Intervention group: Consumption of sage, A Salvigol tablet contains 100 mg of sage extract daily.

Eligibility

Sex/Gender

Female

Age

45 Years to 60 Years

Inclusion criteria

Inclusion criteria: Having menopause symptoms

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
People with menopause symptoms. Timepoint: At the beginning of the study and one month after receiving the sage extract. Method of measurement: Menopausal Symptom Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFereshteh Dadfar

Payame Noor University

fereshtehdadfar2003@yahoo.com+98 71 3622 2255

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026